Dec 18, 2025
•
7 min read
Biotech Financing Returns (Selectively) | 📉 Pfizer's "Value Trap" | 💊 A "Bankrupt" Drug Wins
Dec 17, 2025
📉 Pfizer Falls -5% | 💰 Sobi's $950M Bet | ⚠️ The "Holiday" Binaries
Dec 16, 2025
10 min read
The Full SABCS Debrief | 📉 Sanofi's Phase 3 Miss | ⚠️ Binary Risks Shift
Dec 15, 2025
⚠️ The Week Ahead (ALDX) | 🏆 BioCryst & Innoviva Wins | 📉 Recursion's Fade
🔴 Regulatory Verdicts Today | 🧪 Isomorphic's First Trial | 🤖 Medra's $52M Robots
⚠️ Regulatory Verdicts Tomorrow | 📈 Structure Analyst Upgrades | 🧪 Kelonia's "In Vivo" Win
Syndax Rallies | Incyte's Lymphoma Win | CPI Volatility Ahead
Terns Challenges Novartis | Dyne's DMD Win | $750M in New Raises
Structure Data Imminent | Capricor's 371% Week | Dyne's DMD Readout
Capricor Target Raised to $60 | Intuitive Shares Slide | ImPact’s Urology Win
BMS Stumbles | BioCryst Deal Clears | The New "Data Premium" Trade
Tariffs hit 0% | Otsuka's Renal Win | Small Cap PRV is Back
Stay on the Cutting Edge of Biotech, MedTech, and Pharma.